NU5455 is a potent, selective, and orally active DNA-PKcs inhibitor; it enhances the efficacy and toxicity of parenterally administered topoisomerase inhibitors; it potentiates the activity of locally released doxorubicin in liver tumor xenografts without causing adverse effects.